CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failure

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 896-903

  Borst, Oliver ^a   Schaub, Malte ^a   Walker, Britta ^a   Sauter, Martina ^a   Muenzer, Patrick ^a   Gramlich, Michael ^a   Mueller, Karin ^a   Geisler, Tobias ^a   Lang, Florian ^a   Klingel, Karin ^a   Kandolf, Reinhard ^a   Bigalke, Boris ^a   Gawaz, Meinrad ^a   Zuern, Christine S ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Biomarker; Cardiomyopathy; CXCL16; Myocarditis; Prognosis

Indexed keywords

ALPHA CHEMOKINE; BIOLOGICAL MARKER; CXCL16 PROTEIN, HUMAN; SCAVENGER RECEPTOR;

ADULT; AGED; BIOSYNTHESIS; CARDIOMYOPATHIES; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; TRENDS;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CHEMOKINES, CXC; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, SCAVENGER;

EID: 84908190467     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.08.033     Document Type: Article

References (49)

1. G.M. Felker, R.E. Thompson, and J.M. Hare Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
2. B.J. Maron, J.A. Towbin, and G. Thiene Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
3. C. Kawai From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future Circulation 99 1999 1091 1100
4. G. Szalay, M. Sauter, and M. Haberland Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host Circ Res 104 2009 851 859
5. I. Kindermann, M. Kindermann, and R. Kandolf Predictors of outcome in patients with suspected myocarditis Circulation 118 2008 639 648
6. S. Mavrogeni, K. Bratis, G. Karabela, E. Stavropoulos, E. Sfendouraki, and G. Kolovou Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging Int J Cardiol 164 2013 e3 e4
7. C.S. Zuern, K.A. Muller, and P. Seizer Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy Eur J Heart Fail 15 2013 176 184
8. A. D'Ambrosio, G. Patti, and A. Manzoli The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review Heart 85 2001 499 504
9. F. Escher, R. Vetter, U. Kuhl, D. Westermann, H.P. Schultheiss, and C. Tschope Fractalkine in human inflammatory cardiomyopathy Heart 97 2011 733 739
10. T. Ueland, P. Aukrust, and A. Yndestad Soluble CD40 ligand in acute and chronic heart failure Eur Heart J 26 2005 1101 1107
11. N.G. Frangogiannis, and M.L. Entman Targeting the chemokines in myocardial inflammation Circulation 110 2004 1341 1342
12. A. Yndestad, L. Landro, and T. Ueland Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure Eur Heart J 30 2009 1229 1236
13. O. Borst, P. Munzer, and S. Gatidis The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling Circ Res 111 2012 1297 1307
14. M. Lehrke, S.C. Millington, and M. Lefterova CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans J Am Coll Cardiol 49 2007 442 449
15. M. Minami, N. Kume, and T. Shimaoka Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions Arterioscler Thromb Vasc Biol 21 2001 1796 1800
16. S. Abel, C. Hundhausen, and R. Mentlein The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10 J Immunol 172 2004 6362 6372
17. O. Borst, M. Abed, and I. Alesutan Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX Am J Physiol Cell Physiol 302 2012 C644 C651
18. E. Galkina, B.L. Harry, and A. Ludwig CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall Circulation 116 2007 1801 1811
19. C.P. Dahl, C. Husberg, and L. Gullestad Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling Circ Heart Fail 2 2009 624 632
20. G.J. Sabino, S.J. Hwang, S.C. McAllister, P. Mena, and M.B. Furie Interferon-gamma influences the composition of leukocytic infiltrates in murine lyme carditis Am J Pathol 179 2011 1917 1928
21. + T cells in cardiac valves during inflammatory valvular heart disease Arterioscler Thromb Vasc Biol 24 2004 282 287
22. S. Szmit, M. Jank, and H. Maciejewski Gene expression profiling in peripheral blood nuclear cells in patients with refractory ischaemic end-stage heart failure J Appl Genet 51 2010 353 368
23. L.T. Cooper, K.L. Baughman, and A.M. Feldman The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Circulation 116 2007 2216 2233
24. G.M. Felker, L.K. Shaw, and C.M. O'Connor A standardized definition of ischemic cardiomyopathy for use in clinical research J Am Coll Cardiol 39 2002 210 218
25. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 2012 803 869
26. K. Klingel, M. Sauter, C.T. Bock, G. Szalay, J.J. Schnorr, and R. Kandolf Molecular pathology of inflammatory cardiomyopathy Med Microbiol Immunol 193 2004 101 107
27. A.L. Caforio, S. Pankuweit, and E. Arbustini Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 2636 2648 [2648a-2648d]
28. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
29. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
30. J.L. Fleiss Measuring nominal scale agreement among many raters Psychol Bull 76 1971 378 382
31. P. Seizer, T. Geisler, and B. Bigalke EMMPRIN and its ligand cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy Int J Cardiol 163 2013 299 304
32. I. Kindermann, C. Barth, and F. Mahfoud Update on myocarditis J Am Coll Cardiol 59 2012 779 792
33. K.L. Baughman Diagnosis of myocarditis: death of Dallas criteria Circulation 113 2006 593 595
34. T. Shioi, A. Matsumori, and S. Sasayama Persistent expression of cytokine in the chronic stage of viral myocarditis in mice Circulation 94 1996 2930 2937
35. S. Mavrogeni, K. Bratis, J. Terrovitis, E. Tsagalou, and J. Nanas Fulminant myocarditis. Can cardiac magnetic resonance predict evolution to heart failure? Int J Cardiol 159 2012 e37 e38
36. D.J. Pennell Cardiovascular magnetic resonance Circulation 121 2010 692 705
37. P. Seizer, C.S. Zuern, and J. Maier Electrophysiological characterization of scars detected by contrast enhanced magnetic resonance imaging in patients with non-ischemic cardiomyopathy Int J Cardiol 167 2013 1070 1072
38. H. Mahrholdt, A. Wagner, and C.C. Deluigi Presentation, patterns of myocardial damage, and clinical course of viral myocarditis Circulation 114 2006 1581 1590
39. S. Heymans, E. Hirsch, and S.D. Anker Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 11 2009 119 129
40. S. Heymans Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools Eur Heart J 28 2007 1279 1280
41. L. Gullestad, T. Ueland, L.E. Vinge, A. Finsen, A. Yndestad, and P. Aukrust Inflammatory cytokines in heart failure: mediators and markers Cardiology 122 2012 23 35
42. J.K. Damas, H.G. Eiken, and E. Oie Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure Cardiovasc Res 47 2000 778 787
43. S. Goser, R. Ottl, and A. Brodner Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy Circulation 112 2005 3400 3407
44. E. Cerrato, F. D'Ascenzo, and G. Biondi-Zoccai Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era Eur Heart J 34 2013 1432 1436
45. M. Matloubian, A. David, S. Engel, J.E. Ryan, and J.G. Cyster A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo Nat Immunol 1 2000 298 304
46. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
47. S. Ghio, A. Gavazzi, and C. Campana Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188
48. R. Berger, M. Huelsman, and K. Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
49. H. Kan, and M.S. Finkel Inflammatory mediators and reversible myocardial dysfunction J Cell Physiol 195 2003 1 11